Cargando…
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
Introduction: Opioid deprescription is the process of supervised tapering and safe withdrawal when a potentially inappropriate use is detected. This represents a challenge in chronic non-cancer pain (CNCP) patients who may respond differently to the procedure. Our aim was to analyze the potential im...
Autores principales: | Muriel, Javier, Barrachina, Jordi, Del Barco, Guillermo, Carvajal, Cristian, Escorial, Mónica, Margarit, César, Ballester, Pura, Peiró, Ana María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264765/ https://www.ncbi.nlm.nih.gov/pubmed/37324467 http://dx.doi.org/10.3389/fphar.2023.1200430 |
Ejemplares similares
-
Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study
por: Escorial, Mónica, et al.
Publicado: (2022) -
Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain
por: Agulló, Laura, et al.
Publicado: (2023) -
CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis
por: Ballester, Pura, et al.
Publicado: (2023) -
Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022) -
Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study
por: Agulló, Laura, et al.
Publicado: (2023)